Smart RISUG: A potential new contraceptive and its magnetic field-mediated sperm interaction

International Journal of Nanomedicine

Volumn 4, Issue 1, 2009, Pages 55-64

  Jha, Rakhi K ^a,b   Jha, Pradeep K ^a,c   Guha, Sujoy K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b ChCS University   (India)

^c DR A P J ABDUL KALAM TECHNICAL UNIVERSITY   (India)

Author keywords

Drug distribution; Noninvasive fertility control; Pulsed magnetic field; Smart RISUG; Sperm cell

Indexed keywords

COPPER; CUPROFERROGEL; IRON OXIDE; MALE CONTRACEPTIVE AGENT; STYRENE MALEIC ANHYDRIDE COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BIRTH CONTROL; CELL MEMBRANE; CONTRACEPTION; CONTROLLED STUDY; DRUG DISTRIBUTION; ELECTROMAGNETIC FIELD; MAGNETIC FIELD; MALE; NONHUMAN; PARTICLE SIZE; RAT; SMART REVERSIBLE INHIBITION OF SPERM UNDER GUIDANCE; SPERM; TRANSMISSION ELECTRON MICROSCOPY;

RATTUS;

EID: 66149099319     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s4818     Document Type: Article

References (40)

1. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Stewart FH, Kowal D, editors. Contraceptive technology. 19th revised edition. New York, NY: Ardent Media; 2007; p. 747-826.
2. Sharma RS, Rajanna A, Singh BK, Mathur AK, Mukherjee AK. Current status of development of RISUG: an intravasal injectable male contraceptive. In: Sharma RS, Rajanna A, Rajalakshmi M, editors. Proceedings of the Conference on Recent Advances and Challenges in Reproductive Health Research. New Delhi, India: Indian Society for the Study of Reproduction and Fertility (ISSRF); 2007 Feb. 19-21. 2007; p. 127-140.
3. Sharma S, Sen P, Guha SK, Mukhopadhyay SN. Microbicidal male contraceptive-RISUG induced morphostructural damage in E coli Colloids Surf B Biointerfaces. 2003;32:43-50.
4. Guha SK. Contraceptive for use by male. United States Patent: 1996. 5488,075.
5. Manivannan B, Mishra PK, Lohiya NK. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal. Contraception. 1999;59:137-144.
6. Manivannan B, Bhande SS, Panneerdoss S, Sriram S, Lohiya NK. Safety evaluation of long-term vas occlusion with styrene maleic anhydride and its non-invasive reversal on accessory reproductive organs in langurs. Asian J Androl. 2005;7:195.
7. Sethi N, Srivastava RK, Singh RK. Safety evaluation of a male injectable antifertility agent styrene maleic anhydride, in rats. Contraception. 1989;39:217-226.
8. Sethi N, Srivastava RK, Nath D, Singh RK. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta. J Med Primatol. 1991;20:89-93.
9. Verma K, Misro MM, Singh H, Mahajan S, Ray AR, Guha SK. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive. J Reprod Fertility. 1981;63:539-542.
10. Chaudhury K, Sharma U, Jagannathan NR, Guha SK. Effect of a new injectable male contraceptive on the seminal plasma amino acids studied by proton NMR spectroscopy. Contraception. 2002;66:199-204.
11. Chaudhury K, Bhattacharya AK, Guha SK. Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive. Hum Reprod. 2004;19:1826-1830.
12. Sharma U, Chaudhury K, Jagannathan NR, Guha SK. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites. Reproduction. 2001;122:431-436.
13. Sethi N, Srivastava RK, Nath D, Singh RK. Teratological evaluation of an injectable male antifertility agent, styrene maleic anhydride, in rat. Int J Fertil. 1992;37:183-187.
14. Koul V, Srivastava A, Guha SK. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats. Contraception. 1998;58:227-231.
15. Lohiya NK, Manivannan B, Mishra PK. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys. Int J Androl. 2000;23:36-42.
16. Lohiya NK, Manivannan B, Mishra PK, Sriram S, Bhande SS, Panneerdoss S. Preclinical evaluation for noninvasive reversal following long-term vas occlusion with styrene maleic anhydride in langur monkeys. Contraception. 2005;71:214-226.
17. Jha RK, Jha PK, Rana SVS, Guha SK. Spermicidal action of styrene maleic anhydride polyelectrolyte in combination with magnetic and electrically conductive particles. Int J Pharmacol. 2009;5(1):1-12.
18. Guha SK. An improved reversible contraceptive for male and female. Canada Patent: 2007. 2367414.
19. Gaganidze E, Esquinazi P, Ziese M. Vibrating ferromagnets in a magnetic field. Journal of Alloys and Compounds. 2000;310:144-152.
20. Zrínyi M, Barsi L, Büki A. Ferrogel: a new magneto-controlled elastic medium. Polymer Gels and Networks. 1997;5:415-427.
21. Raikher YL, Stolbov OV. Magnetodeformational effect in ferrogel samples. JMMM. 2003;258-259, 477-479.
22. Lebedev VT, Torok G, Cser L, et al. Magnetic phase ordering in ferrogels under applied field. JMMM. 1999;201:136-139.
23. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23:1553-1561.
24. Gruttner C, Rudershausen S, Teller J. Improved properties of magnetic particles by combination of different polymer materials as particle matrix. J Magn Magn Mater.. 2001;225:1-7.
25. Gupta AK, Curtis A. Surface modification of superparamagnetic iron oxide nanoparticles and their intracellular uptake. Eur Cells Mater.. 2002;4:101-102.
26. Schopf B, Neuberger T, Schulze K, et al. Methodology description for detection of cellular uptake of PVA coated superparamagnetic iron oxide nanoparticles (SPION) in synovial cells of sheep. JMMM. 2005;293:419.
27. Hofmann H, Juillerat J, Petri-Fink A, Chastellain M. Development of biocompatible functionalized superparamagnetic iron oxide nanoparticles for human cancer cell uptake. Eur Cell Mater.. 2004;7:14.
28. Roblero L, Guadarrama A, Lopez T, Zegers-Hochschild F. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod Fertil Dev. 1996;8:871-874.
29. Gravance CG, Garnen DL, Miller MG, Berger T. Fluorescent probes and flow cytometry to assess rat sperm integrity and mitochondrial function. Reprod Toxicol. 2001;15:5-10.
30. Younglai EV, Holt D, Brown P, Jurisicova A, Casper RF. Sperm swim-up techniques and DNA fragmentation. Hum Reprod. 2001;16:1950-1953.
31. Marinelli F, Bersani F, Ognibene A, Matteuci A, Santi S, Maraldi NM. Effect of the extremely low frequency (ELF) magnetic fields on cell membrane. Eng Med Biol Soc. 1992;1:309-311.
32. Guha SK, Ansari S, Anand S, Farooq A, Misro MM, Sharma DN. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer. Contraception. 1985;32:109-118.
33. Misro M, Guha SK, Singh H, Mahajan S, Ray AR, Vasudevan P. Injectable non-occlusive chemical contraception in the male-I. Contraception. 1979;20:467-473.
34. Guha SK. Biophysical mechanism-mediated time-dependant effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive. Asian J Androl. 2007;9:221-227.
35. Chaki SP, Das HC, Misro MM. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG. Contraception. 2003;67:73-78.
36. Guha SK, Singh G, Anand S, Ansari S, Kumar S, Koul V. Phase I clinical trial of an injectable contraceptive for the male. Contraception. 1993;48:367-375.
37. Guha SK, Singh G, Ansari S, et al. Phase II clinical trial of a vas deferens injectable contraceptive for the male. Contraception. 1997;56:245-250.
38. Marchal G, Van Hecke P, Demaerel P, Decrop E, Kennis C, Schueren E. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5T. Am J Roentgen. 1989; 152:771-775.
39. Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res. 1996;56:4694-4701.
40. Makhluf SBD, Qasem R, Rubinstein S, Gedanken A, Breitbart H. Loading magnetic nanoparticles into sperm cells does not affect their functionality. Langmuir. 2006;22:9480-9482.